Company intelligence / Profile preview

Viatar CTC Solutions

Lowell, Massachusetts, United Statessec.gov ↗

Ownership: Private
Employees: ~2
Development stage: Other

Overview

Viatar CTC Solutions was a medical device company focused on developing devices to diagnose and treat metastatic cancer by targeting circulating tumor cells. Its pipeline included the Viatar Therapeutic Oncopheresis System (pre-clinical for therapeutic CTC removal) and the Viatar Collection System for Molecular Analysis (commercial for research use only diagnostics).

Therapeutic areas: Oncology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Viatar CTC Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viatar CTC Solutions.

Explore the full profile